BENDHEIM JACK (President and CEO) sold 27.7% of their position (14.08K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $727.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/18/2026ACC: 0001104659-26-017198
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-14.08K
Net shares
Net seller
$727.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
14.08K disposed
Non-Derivative Transactions3
Class A Common Stock
Indirect
Shares
−7.04K
Price / share
$51.96
Trade value
$365.82K
% of position
13.9%
2/13/2026
50.76K→43.72K
Class A Common Stock
Indirect
Shares
−6.82K
Price / share
$51.38
Trade value
$350.60K
% of position
15.6%
2/18/2026
43.72K→36.90K
Class A Common Stock
Indirect
Shares
−216.00
Price / share
$51.97
Trade value
$11.23K
% of position
0.6%
2/18/2026
36.90K→36.68K
Total
Net shares
−14.08K
Net value
-$727.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 2/13/2026 | S · Sale | −7.04K | $51.96 | $365.82K | 13.9% | 50.76K | 43.72K |
| Class A Common Stock Indirect | 2/18/2026 | S · Sale | −6.82K | $51.38 | $350.60K | 15.6% | 43.72K | 36.90K |
| Class A Common Stock Indirect | 2/18/2026 | S · Sale | −216.00 | $51.97 | $11.23K | 0.6% | 36.90K | 36.68K |
| Total | −14.08K | -$727.65K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
DirectShares owned16.84K
Total
16.84K direct16.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported